Abstract:Key Points Although the concept of suppression mediated by T cells was proposed originally 30 years ago, recent studies in animal models of autoimmunity have rekindled interest in the existence of a subset of lymphocytes that specifically suppress immune responses. Some T cells that have suppressor activity are part of a unique lineage of CD4+ T cells that are 'naturally occurring' and are present in the thymus and peripheral lymphoid tissues of mice and humans. Other types of suppressor T cell can be induced from conventional CD4+ T cells by specific experimental manipulations in vitro. The 'naturally occurring' suppressor T-cell population can be identified by expression of the CD25 antigen. However, CD25 can be expressed by any activated T cell, so it cannot be used as a suppressor-cell marker after perturbation of the immune system. CD4+CD25+ T cells are potent suppressors of the activation of both CD4+ and CD8+ T cells in vitro. Suppression is mediated by a cell-contact-dependent, cytokine-independent mechanism. CD4+CD25+ T cells are also potent suppressors of a large number of animal models of autoimmunity, including gastritis, thyroiditis, inflammatory bowel disease and insulin-dependent diabetes mellitus. Both suppressor cytokines — such as interleukin-4 (IL-4), IL-10 and transforming growth factor-β — and a cell-contact-dependent mechanism might have a role in the suppression of disease in vivo. In vitro, CD4+CD25+ T cells can mediate suppression by acting solely on responder CD4+CD25− effector cells. It remains possible that other cell types (such as antigen-presenting cells, B cells and natural killer cells) might also be targets of suppression, particularly in vivo. CD4+CD25+ T cells require IL-2 for their differentiation in the thymus and for their survival and maintenance in peripheral lymphoid tissues. Their physiological target antigen is unknown, but some studies indicate that they might recognize antigens from the target organ in organ-specific autoimmunity. Cells that have suppressor activity can be generated from CD4+CD25− cells by stimulation under conditions in which co-stimulation is limiting (in the presence of IL-10 or immature dendritic cells). Most frequently, these induced suppressors function by secreting suppressor cytokines, such as IL-10. The enhancement of suppressor-cell function might be a target for immunotherapeutic approaches for the treatment of autoimmunity. By contrast, the elimination of suppressor cells or the inhibition of their function might prove to be useful for the induction of tumour immunity or the treatment of chronic infectious diseases.

Do adaptive immune cells suppress or activate innate immunity?

Adaptive Immune Cells Temper Initial Innate Responses

NK cells regulating T cell responses: mechanisms and outcome

Innate-adaptive immunity interplay and redox regulation in immune response

The interaction of innate immune and adaptive immune system

Research progress on negative regulation of adaptive immune response by NK cells

Hyper Innate Responses In Neonates Lead To Increased Morbidity And Mortality After Infection

Regulatory Activity of Activated Murine Peripheral Cd4(+)Cd25(-) T Cells: A Possible Mechanism of Feedback Regulation on Adaptive Immunity

Adaptive immunity shapes innate and epithelial cell landscapes by silencing tonic IFN-gamma in innate lymphoid cells during homeostasis.

Mechanisms underlying immunosuppression by regulatory cells

A20 intrinsically influences human effector T‐cell survival and function by regulating both NF‐κB and JNK signaling

The role of antigen-competitive dynamics in regulating the immune response

Apoptotic Cells and Innate Immune Stimuli Combine to Regulate Macrophage Cytokine Secretion

One Way to Pathogenesis, Many Ways to Homeostasis

NK Cells Promote Type 1 T Cell Immunity Through Modulating the Function of Dendritic Cells During Intracellular Bacterial Infection

CD4+CD25+ suppressor T cells: more questions than answers

Regulation of Interferon and Toll‐like Receptor Signaling During Macrophage Activation by Opposing Feedforward and Feedback Inhibition Mechanisms

Steady-state, therapeutic, and helminth-induced IL-4 compromise protective CD8 T cell bystander activation

T Cell-Extrinsic Cd18 Attenuates Antigen-Dependent Cd4(+) T Cell Activation in Vivo

Interferon-mediated NK cell activation is associated with limited neutralization breadth during SARS-CoV-2 infection

IL-10 dependent adaptation allows macrophages to adjust inflammatory responses to TLR4 stimulation history